Effect of Pulse Rate Changes on Clinical Outcome
Study Details
Study Description
Brief Summary
Objectives: To evaluate the effect of pulse rate changes on the clinical response and stimulation related pain symptoms in sacral neuromodulation (SNM) treatment.
Materials and Methods: This pilot study evaluated the effect of 4 different pulse rates (5.2Hz-10Hz-21Hz-40Hz) in patients with suboptimal response to SNM. The effect of each frequency was evaluated over test period of 6 days. To avoid carry over effect, stimulation was kept off for 24 hours between consecutive test periods. The last 3 days of every test period, a voiding diary (VD) and questionnaire was filled in. The changes on clinical response and pain symptoms were compared between the four pulse-rates using multivariate analysis.
Results: Fifty patients were included of which 40 (80%) were female. Mean age was 55.5yr (SD 12.3). Forty-one patients (82%) had overactive bladder symptoms and 9 (18%) had chronic non-obstructive urinary retention. No significant difference was found regarding clinical outcome (VD and questionnaire) between the different pulse rates. Furthermore, none of the four pulse rates was significantly related to the occurrence of SNM-related pain. However, on individual basis, patients appear to benefit from changing the pulse rate concerning both treatment efficacy and stimulation related pain.
Conclusions: On group level, none of the four pulse rates in this study appears to have a significantly different effect on clinical outcome or SNM-related pain. However, a tailor-made approach for optimizing treatment efficacy by changing the pulse rate might be useful.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Pulse Rate Change Patients are subjected to different pulse rate settings of their neurostimulator. The effect of pulse rate changes on clinical outcome is measured. |
Other: Pulse Rate Change
Different pulse rate settings of the implantable neurostimulator
|
Outcome Measures
Primary Outcome Measures
- Improvement in voiding diary variables []
Secondary Outcome Measures
- Improvement in subjective voiding symptoms []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients who have been implanted with a neurostimulator for overactive bladder symptoms or urinary retention
-
Patients with suboptimal effect of their neurostimulator
Exclusion Criteria:
- Patients with 100% effect of their neurostimulator
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Maastricht University Medical Centre | Maastricht | Limburg | Netherlands | P.O. box 5800, 6202 AZ |
Sponsors and Collaborators
- Maastricht University Medical Center
Investigators
- Principal Investigator: Philip van Kerrebroeck, M.D., Ph.D., Maastricht University Medical Centre
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MEC 07-2-083 (5266)